Busulfan
- Strength
- 6 mg/mL
- Form
- Injection, Solution, Concentrate
- Class
- Alkylating Drug
Sagent Pharmaceuticals
busulfan
Listed by Waylis Therapeutics LLC
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Alkylating Drug |
| Approval route | NDA — original brand approval |
| NDC code | 80725-620 |
| FDA application | NDA009386 |
| RxNorm concept | 105551 |
| Package sizes listed | 1 |
| Marketed since | May 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Sagent Pharmaceuticals
Amneal Pharmaceuticals LLC
Hospira, Inc.
Eugia US LLC
Meitheal Pharmaceuticals Inc.
Meitheal Pharmaceuticals Inc.
Accord Healthcare, Inc
Pharmascience Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.